Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 36, Issue 2, 2003, Pages 19-25

  Butler, Jay C ^a   Lennox, Jeffrey L ^a,b   McDougal, Linda K ^c   Sutcliffe, Joyce A ^d   Tait Kamradt, Amelia ^e   Tenover, Fred C ^c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Rib X Pharmaceuticals   (United States)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ERYTHROMYCIN; RNA 23S;

ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; DRUG EFFECT; EPIDURAL ABSCESS; GENETICS; HUMAN; LOBAR PNEUMONIA; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; POINT MUTATION; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; EPIDURAL ABSCESS; ERYTHROMYCIN; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; POINT MUTATION; RNA, RIBOSOMAL, 23S; STREPTOCOCCUS PNEUMONIAE;

EID: 0037440067     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/344965     Document Type: Article

References (0)